Overview

Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus

Status:
Completed

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and pharmacokinetics of double-blind S-707106 alone and in combination with open-label metformin in patients with type 2 diabetes mellitus

Phase:

Phase 1

Details

Lead Sponsor:

Shionogi

Treatments:

Metformin